Lung Diseases, Obstructive  >>  Arnuity Ellipta (fluticasone furoate)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Arnuity Ellipta (fluticasone furoate) / GSK
NCT00398645 / 2006-005228-18: A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma.

Completed
2
648
US, Canada, Europe, RoW
GW685698X 200mcg,GW685698X 200mcg and 400mcg, GW685698X 200mcg, GW685698X 200mcg and 400mcg
GlaxoSmithKline
Asthma
08/07
08/07
NCT00603746 / 2007-004458-98: A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.

Completed
2
627
US, Canada, Europe, RoW
GW685698X
GlaxoSmithKline
Asthma
09/08
09/08
NCT00603382 / 2007-004442-32: A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.

Completed
2
599
US, Canada, Europe, RoW
GW685698X, Placebo
GlaxoSmithKline
Asthma
10/08
10/08
NCT00603278 / 2007-004459-13: A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy.

Completed
2
622
Europe
GW685698X, placebo
GlaxoSmithKline
Asthma
11/08
11/08
NCT00766090: Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma

Completed
2
190
US
GW685698X
GlaxoSmithKline
Asthma
03/09
03/09

Download Options